• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生合并代谢紊乱患者前列腺细胞的凋亡和增殖。

Apoptosis and proliferation of the prostate cells in men with benign prostatic hyperplasia and concomitant metabolic disorders.

机构信息

Department of Histology and Developmental Biology, Pomeranian Medical University, Szczecin, Poland.

Department of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian Medical University, Szczecin, Poland.

出版信息

Histol Histopathol. 2018 Apr;33(4):389-397. doi: 10.14670/HH-11-934. Epub 2017 Sep 26.

DOI:10.14670/HH-11-934
PMID:28948599
Abstract

INTRODUCTION

Apoptosis and proliferation of prostate cells are associated with both physiological increase and hyperplasia of the prostate. The aim of this study was to determine the contribution of metabolic syndrome to the processes of apoptosis and proliferation in gland epithelial cells and prostatic stromal cells in men with BPH.

SUBJECTS AND METHODS

The study involved 151 men, aged 52-89 years, receiving pharmacological treatment for BPH. The men were divided into two groups: those with and those without metabolic syndrome. The serum levels of the parameters were determined. Reactions for the identification of apoptosis (TUNEL) and proliferation (PCNA) in cells were also performed.

RESULTS

The relationships between the number of TUNEL(+) and PCNA(+) cells and metabolic syndrome were not observed. It was found that the total number of TUNEL(+) cells in the prostate stroma correlated negatively with the levels of high-density lipoprotein and insulin-like growth factor-1. The analysis of the correlations in BPH patients with and without metabolic syndrome demonstrated that the only parameter correlating with the number of PCNA(+) cells in the prostate stroma was insulin resistance.

CONCLUSION

Metabolic syndrome in patients with BPH had no impact on the number of TUNEL(+) and PCNA(+) cells in the prostate gland. However, the disturbed levels of metabolic parameters, and deviations of anthropometric parameters from normal may influence the number of apoptotic and proliferating cells.

摘要

介绍

前列腺细胞的凋亡和增殖与前列腺的生理增生和增生有关。本研究的目的是确定代谢综合征对 BPH 患者前列腺上皮细胞和基质细胞凋亡和增殖过程的贡献。

研究对象和方法

本研究涉及 151 名年龄在 52-89 岁之间的男性,他们正在接受 BPH 的药物治疗。这些男性被分为两组:有代谢综合征的组和没有代谢综合征的组。测定了血清参数水平。还进行了细胞凋亡(TUNEL)和增殖(PCNA)鉴定的反应。

结果

未观察到 TUNEL(+)和 PCNA(+)细胞数量与代谢综合征之间的关系。结果发现,前列腺基质中总 TUNEL(+)细胞的数量与高密度脂蛋白和胰岛素样生长因子-1的水平呈负相关。在有和没有代谢综合征的 BPH 患者中进行的相关性分析表明,与前列腺基质中 PCNA(+)细胞数量相关的唯一参数是胰岛素抵抗。

结论

BPH 患者的代谢综合征对前列腺中 TUNEL(+)和 PCNA(+)细胞的数量没有影响。然而,代谢参数水平的紊乱以及人体测量参数偏离正常值可能会影响凋亡和增殖细胞的数量。

相似文献

1
Apoptosis and proliferation of the prostate cells in men with benign prostatic hyperplasia and concomitant metabolic disorders.良性前列腺增生合并代谢紊乱患者前列腺细胞的凋亡和增殖。
Histol Histopathol. 2018 Apr;33(4):389-397. doi: 10.14670/HH-11-934. Epub 2017 Sep 26.
2
Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.良性前列腺增生和睾酮缺乏综合征男性患者的激素浓度、代谢紊乱以及雄激素和雌激素-α受体的免疫表达
Folia Histochem Cytobiol. 2015;53(3):227-35. doi: 10.5603/fhc.a2015.0026. Epub 2015 Sep 24.
3
[Effect of hypertension on cell proliferation and apoptosis in benign prostatic hyperplasia].
Zhonghua Nan Ke Xue. 2005 Feb;11(2):94-7.
4
Apoptotic versus proliferative activities in human benign prostatic hyperplasia.人类良性前列腺增生中的凋亡与增殖活性
Hum Pathol. 1996 Jul;27(7):668-75. doi: 10.1016/s0046-8177(96)90396-2.
5
Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.α1肾上腺素能受体拮抗剂特拉唑嗪和多沙唑嗪可诱导良性前列腺增生患者的前列腺细胞凋亡,而不影响细胞增殖。
J Urol. 1999 Jun;161(6):2002-8.
6
Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
J Urol. 1997 Jul;158(1):217-21. doi: 10.1097/00005392-199707000-00074.
7
The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.良性前列腺增生患者代谢综合征与前列腺生长之间的相关性。
Eur Urol. 2007 Jan;51(1):199-203; discussion 204-6. doi: 10.1016/j.eururo.2006.05.040. Epub 2006 Jun 14.
8
Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.高胰岛素血症作为良性前列腺增生发展的一个风险因素。
Eur Urol. 2001 Feb;39(2):151-8. doi: 10.1159/000052430.
9
Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.稻壳提取物通过减轻大鼠炎症和调节细胞增殖来抑制良性前列腺增生。
J Med Food. 2016 Aug;19(8):746-54. doi: 10.1089/jmf.2016.3686. Epub 2016 Jul 21.
10
Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.α1肾上腺素能受体拮抗剂和/或非那雄胺治疗良性前列腺增生后的凋亡和增殖指数
Urol Int. 2002;69(4):287-92. doi: 10.1159/000066120.

引用本文的文献

1
[ Bunge flower extract inhibits benign prostatic hyperplasia in rats].[邦奇花提取物抑制大鼠良性前列腺增生]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Oct 20;42(10):1503-1510. doi: 10.12122/j.issn.1673-4254.2022.10.09.
2
Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway.小檗碱通过 Nrf2-ARE 通路改善良性前列腺增生中的氧化应激和细胞凋亡。
Redox Rep. 2021 Dec;26(1):1-9. doi: 10.1080/13510002.2021.1871814.
3
Morphological and functional alterations of the prostate tissue during clinical progression in hormonally-naïve, hormonally-treated and castration-resistant patients with metastatic prostate cancer.
激素初治、激素治疗及去势抵抗性转移性前列腺癌患者临床进展过程中前列腺组织的形态学和功能改变。
Oncol Lett. 2020 Nov;20(5):201. doi: 10.3892/ol.2020.12064. Epub 2020 Sep 8.